Children and young people have higher risks of rare vascular and inflammatory diseases up to 12 months after a first COVID-19 ...
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback